Moderna Inc. Key Takeaways 47th Annual Global Healthcare Conference

Goldman Sachs hosted Moderna at their 47th Annual Global Healthcare Conference, focusing on the company's pipeline progress in melanoma and oncology, and their financial outlook involving revenue growth and cost rationalization.

Key Takeaways

• 1.Management reiterated expectations for up to 10% revenue growth in FY26, with revenue diversification and an improved financial profile as key pillars of their growth outlook.
• 2.The expiry of PFE's EU COVID-era contract in 2026 presents a $1.7bn market opportunity in 2027 for Moderna's respiratory vaccines.
• 3.Moderna provided positive updates on its melanoma vaccine candidate 'intismeran', emphasizing its potential to become standard-of-care in the adjuvant setting.

Table of Contents

• Presenters: Jamey Mock (CFO)
• Key Takeaways
• Valuation/Risks
• Disclosure Appendix

Document Preview

Page 1 of 1

Subscribe for full accessStart Free Trial